Personalized Medicine – News and Features
News
Abbott to Collaborate with Pfizer Inc on Companion Diagnostic Test
Collaboration will select patient candidates for novel investigational non-small cell lung cancer therapy.
News
Horizon Discovery Sign Commercial Screening Agreement with Silicos
Agreement covers testing of Silicos lead compounds on human isogenic cell-lines comprising specific genotypes targeted by the compound series.
News
Cancer Biomarker Identification Software Tools Earn Certification
caCORRECT and omniBioMarker are being made available to cancer researchers to remove artifacts and identify and validate biomarkers from microarray data.
News
New Biomarker Predicts Response to Hepatitis C Treatment
Newly identified genetic marker that predicts response to hepatitis C treatments may also explain difference in rates of response among racial and ethnic groups.
News
NIH-Funded Researchers Sequence Exomes of 12 People
New method demonstrated by a team supported by NIH may help in efforts to pinpoint disease-causing genes.
News
Cellular Dynamics International Appoints Leroy Hood, M.D., Ph.D., and George Church, Ph.D., to its Scientific Advisory Board
Cellular Dynamics International (CDI) announced today the appointment of Leroy Hood, M.D., Ph.D., and George Church, Ph.D., two of the world’s leading scientists in molecular biotechnology and genomics, to the company’s scientific advisory board. Hood and Church join stem cell pioneer James Thomson, V.M.D., Ph.D., to advise the company on strategic plans for developing induced pluripotent stem (iPS) cells into drug discovery tools and, eventually, personalized therapeutics.
News
454 Life Sciences and Roche NimbleGen Announce Collaboration with Eli Lilly and SeqWright
The collaboration is aimed to sequence genomic regions associated with psychiatric disease.
News
Horizon Discovery Sign License Agreement with Ortho Biotech Oncology Research & Development
The agreement covers the licensing of certain X-MAN cell lines including major cancer causing genes and their matched normal genetic backgrounds.
News
Covance to Acquire Seattle-Based Gene Expression Laboratory from Merck & Co
Under the terms of the agreement Merck has committed to a five-year $145 million contract to purchase genomic analysis services from Covance.
News
GeneGo Awarded NIH Grant to Develop Pharmacogenomics Software Suite
The SBIR grant will be used to develop a database and systems biology tool-set specifically designed for pharmacogenomic research.
Advertisement